Testing a glue-like treatment for abnormal brain vessel leaks in children
Part of Brain & nervous system, Genetic & congenital, Heart & circulation clinical trials.
This trial studies a device that delivers a special “embolic” material (often described as glue) to treat a type of abnormal connection in the brain’s blood vessels (dAVF). It may help by blocking the leaking or risky blood flow, and it will be compared against how doctors handle eligible cases with other embolic materials.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be under 22 years old
- You (and a parent/guardian) must be able to follow the study schedule and check-ins
- A parent/guardian must sign consent before any study procedures start
- You must have an intracranial dAVF suitable for treatment with the PHIL material, or have been treated before with other embolic materials
- You should not have a brain/head-and-neck cancer mass or be in radiation treatment for that type of cancer
- You must be able to receive imaging tests like DSA, CT, and MRI/MRA if needed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new liquid material (called a liquid embolic system) that is injected into the abnormal blood vessels in the brain to block them off. It is for people who have a cerebrovascular malformation and can be treated with a catheter from inside the blood vessel.
This trial tests a liquid embolic agent (a gel-like material) injected into the blood vessels of a brain arteriovenous malformation (AVM) to block abnormal blood flow. It’s for people aged 18 to 80 with certain types of AVMs that doctors think can be treated this way.
This trial tests whether a minimally invasive procedure to block a specific type of abnormal connection between brain blood vessels can help preserve or improve memory and thinking. It is being studied in people who have not yet had bleeding from this condition.
This trial tests a procedure that blocks blood flow to the membrane around the brain to treat a chronic subdural hematoma (a slow buildup of blood pressing on the brain). It may help avoid surgery and reduce symptoms like headaches, confusion, or weakness.
This trial tests a new imaging system and tiny catheter that lets doctors see inside brain blood vessels more clearly during a planned angiogram. It may help people who need follow-up imaging after previous treatment or a diagnostic look at their vessels.
This trial tests whether butylphthalide, given after a procedure to remove a blood clot from the brain, can help reduce dangerous brain swelling. If you've had a severe stroke and recently had a clot-removal procedure, this drug might improve your recovery.
Hear when a new Arterio-venous Fistula trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.